Call Us 080-41656200 (Mon-Sat: 10AM-8PM)
Free Shipping above Rs. 1499
Cash On Delivery*

The Legal Challenges Faced By The Pharmaceutical Industry In India


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days


Check Your Delivery Options

Rs. 3,651

Availability: In stock

  • Product Description

Who is world's supplier for affordable medicines to the developing countries? Who created exception to the normal tests of patentability requirement required under Article 27.1 of the TRIPS Agreement. The credit certainly goes to India for its daring move in the interpretation of Section 3(d) of Patent Amendment Act 2005. The question is no longer whether Section 3(d) is compatible with the TRIPS Agreement , but whether it does more harm to the domestic pharmaceutical industry than good? The efficacy requirement will be analysed taking into considerations the importance of second medical use. Utility patent or known as petty innovations are considered of importance to the generic pharmaceutical industry. Utiliy patents widely recognised in countries such as Malaysia under Section 17 of the Patents Act 1983. Utility patent must be taken into consideration by Indian patent system for a balanced patent system. The legal challenges faced by India to supply affordable medicines preventing evergreening of patents with the full enforcement of Section 3(d), grounds of compulsory licensing, are certainly a continuing challenge for our world leading pharmaceutical generic drug manufacturer

Product Specifications
SKU :COC67185
AuthorKamini Shanmugaiah
Number of Pages52
Publishing Year2013-02-24T00:00:00.000
Edition1 st
Book TypeLaw
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-07-08 00:00:00